Matching Items (865)
128347-Thumbnail Image.png
Description

Bismuth drugs, despite being clinically used for decades, surprisingly remain in use and effective for the treatment of Helicobacter pylori infection, even for resistant strains when co-administrated with antibiotics. However, the molecular mechanisms underlying the clinically sustained susceptibility of H. pylori to bismuth drugs remain elusive. Herein, we report that

Bismuth drugs, despite being clinically used for decades, surprisingly remain in use and effective for the treatment of Helicobacter pylori infection, even for resistant strains when co-administrated with antibiotics. However, the molecular mechanisms underlying the clinically sustained susceptibility of H. pylori to bismuth drugs remain elusive. Herein, we report that integration of in-house metalloproteomics and quantitative proteomics allows comprehensive uncovering of the bismuth-associated proteomes, including 63 bismuth-binding and 119 bismuth-regulated proteins from Helicobacter pylori, with over 60% being annotated with catalytic functions. Through bioinformatics analysis in combination with bioassays, we demonstrated that bismuth drugs disrupted multiple essential pathways in the pathogen, including ROS defence and pH buffering, by binding and functional perturbation of a number of key enzymes. Moreover, we discovered that HpDnaK may serve as a new target of bismuth drugs to inhibit bacterium-host cell adhesion. The integrative approach we report, herein, provides a novel strategy to unveil the molecular mechanisms of antimicrobial metals against pathogens in general. This study sheds light on the design of new types of antimicrobial agents with multiple targets to tackle the current crisis of antimicrobial resistance.

ContributorsWang, Yuchuan (Author) / Hu, Ligang (Author) / Xu, Feng (Author) / Quan, Quan (Author) / Lai, Yau-Tsz (Author) / Xia, Wei (Author) / Yang, Ya (Author) / Chang, Yuen-Yan (Author) / Yang, Xinming (Author) / Chai, Zhifang (Author) / Wang, Junwen (Author) / Chu, Ivan K. (Author) / Li, Hongyan (Author) / Sun, Hongzhe (Author) / College of Health Solutions (Contributor)
Created2017-04-19
128638-Thumbnail Image.png
Description

It remains challenging to predict regulatory variants in particular tissues or cell types due to highly context-specific gene regulation. By connecting large-scale epigenomic profiles to expression quantitative trait loci (eQTLs) in a wide range of human tissues/cell types, we identify critical chromatin features that predict variant regulatory potential. We present

It remains challenging to predict regulatory variants in particular tissues or cell types due to highly context-specific gene regulation. By connecting large-scale epigenomic profiles to expression quantitative trait loci (eQTLs) in a wide range of human tissues/cell types, we identify critical chromatin features that predict variant regulatory potential. We present cepip, a joint likelihood framework, for estimating a variant’s regulatory probability in a context-dependent manner. Our method exhibits significant GWAS signal enrichment and is superior to existing cell type-specific methods. Furthermore, using phenotypically relevant epigenomes to weight the GWAS single-nucleotide polymorphisms, we improve the statistical power of the gene-based association test.

ContributorsLi, Mulin Jun (Author) / Li, Miaoxin (Author) / Liu, Zipeng (Author) / Yan, Bin (Author) / Pan, Zhicheng (Author) / Huang, Dandan (Author) / Liang, Qian (Author) / Ying, Dingge (Author) / Xu, Feng (Author) / Yao, Hongcheng (Author) / Wang, Panwen (Author) / Kocher, Jean-Pierre A. (Author) / Xia, Zhengyuan (Author) / Sham, Pak Chung (Author) / Liu, Jun S. (Author) / Wang, Junwen (Author) / College of Health Solutions (Contributor)
Created2017-03-16